stock logo

78% Buy

Ajanta Pharma Share Price

AJANTPHARM

₹3,072.20+₹87.70 (2.94%) TodayLast updated on 05 Nov, 2024 | 13:07 IST

Ajanta Pharma Share Price Chart

Please wait...
  • About Ajanta Pharma
  • Fundamentals
  • Events
  • More
  • News

About Ajanta Pharma

Ajanta Pharma Financials

arrow
Market cap
Market Cap Switch₹37,280 Crs
Open
₹3,001.35
Close
₹2,984.50
Circuit range
₹3,581.40 - ₹2,387.60
Day range
₹3,001.35 - ₹3,095.05
Year range
₹1,783.50 - ₹3,485.00
Volume
1,13,496
Avg. traded
₹3,069.24
Revenue (12m)
₹4,491 Crs
Ajanta PharmaAjanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

Ajanta Pharma Key indicators

arrow
52 week high
₹3,485.00
52 week low
₹1,783.50
P/E ratio
42.91
P/B ratio
9.94
ROE
24.26%
ROCE
33.15%
Dividend yield
1.62%
Debt/Equity ratio
EPS
64.12

Learn more

Investment checklist: (5/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

78%

Hold

11%

Sell

11%

This analysis is based on the reviews of 9 experts in the last 7 days

Ajanta Pharma Fundamentals

Ajanta Pharma Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

30.18%

Net profit margin

19.71%

ROE

24.26%

ROA

18.68%

ROCE

33.15%

Learn more

Ajanta Pharma Shareholder returns

arrow
1 day
-3.29%
1 week
+2.12%
1 month
-10.23%
3 months
+5.52%
1 year
+63.46%
3 years
+104.58%
5 years
+345.67%

Ajanta Pharma Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹3,088.95
₹2,984.50
-3.29%
Fri, Nov 1 2024
₹3,073.00
₹3,086.15
+0.70%
Thu, Oct 31 2024
₹2,996.65
₹3,064.70
+2.27%
Wed, Oct 30 2024
₹2,924.35
₹2,996.65
+2.47%
Tue, Oct 29 2024
₹2,959.60
₹2,924.35
+0.06%
Mon, Oct 28 2024
₹2,942.30
₹2,922.60
-1.57%
Fri, Oct 25 2024
₹2,951.00
₹2,969.30
-0.06%
Thu, Oct 24 2024
₹2,961.90
₹2,970.95
+0.83%

Ajanta Pharma Shareholding Pattern

arrow

Promoters (66.26%)

Mutual Funds (14.93%)

Retail and other (7.52%)

Foreign institutions-FII (9.11%)

Other domestic institutions (2.18%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹28/share

    Ex date 06 Nov 2024

    expand tab
  • Dividend • ₹26/share

    Ex date 08 Feb 2024

    expand tab
  • Dividend • ₹15/share

    Ex date 04 Aug 2023

    expand tab
  • Dividend • ₹10/share

    Ex date 04 Aug 2023

    expand tab
  • Dividend • ₹7/share

    Ex date 11 Nov 2022

    expand tab
  • Bonus • 1:2

    Ex date 22 Jun 2022

    expand tab
  • Dividend • ₹9.5/share

    Ex date 09 Nov 2021

    expand tab

Learn more

FAQs on Ajanta Pharma